Addex Therapeutics
Price & Volume
Stats
See more52W Range | $5.41-$12.04 |
Market Cap | $8.5M |
Shares Short | 7,260 |
Financials
See moreRevenue (12 Mos) | $158,538 |
Revenue Growth (YoY) | -15% |
Gross Profit (12 Mos) | -$525,653 |
Diluted EPS | -$9.12 |
News
See moreYahoo Finance • 9 days ago
Addex Reports Neurosterix On Track To Complete Phase 1 Trial For Schizophrenia Drug NTX-253
Yahoo Finance • 11 days ago
Addex GABAB PAM Candidate Demonstrates Robust Anti-Tussive Activity in Non-Human Primate Chronic Cough Model
Yahoo Finance • 3 months ago
Addex Announces Publication of Preclinical Data Supporting Potential of mGlu7 Negative Allosteric Modulators to Transform Anxiety and Fear-Related Disorder Treatment
Yahoo Finance • 5 months ago
Addex Amends its at the Market Offering Agreement With H.C. Wainwright & Co.
About
CEO | Mr. Timothy Mark Dyer |
Address | Chemin des Mines, 9, Geneva, Switzerland, 1202 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 2 |